In this Healthed lecture, infectious diseases physician, Prof Tony Cunningham AO explains which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax). Prof Cunningham also describes how immunocompromised patients fit into one of three basic categories. Each of these categories warrants a different degree of caution, and each warrants a different approach to vaccination choice.
This educational activity was developed by Healthed at the request of and with funding from GSK.
Based on this educational activity, complete these learning modules to gain additional CPD.
Browse the latest podcasts from Healthed.
You have completed the Educational Activities component of this resource.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
